CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

18 December 2018

6 tests for assessing cognition in Parkinson’s disease

Cognitive dysfunction in Parkinson’s disease remains a significant, unmet therapeutic need for patients; as such it is vital that there is rigorous research into the topic. Here we will discuss six CANTAB tasks that can address this research gap. 

5 December 2018

Normative data from linear and non-linear quantile regression in CANTAB: cognition in mid-to-late life in an epidemiological sample

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring recently published the first study to derive normative CANTAB data from quantile regressions of cognitive test performance for a large epidemiological sample of adults aged 57-84 years.

7 November 2018

Emotion recognition biases in alcohol use disorder

Researcher at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), Clara Freeman, shared with us about why she chose the CANTAB Emotion Recognition Task for her latest publication

1 November 2018

Why is it important to assess cognition in criminal cases?

Dr Seán Haldane is a Consultant Neuropsychologist and expert witness who provides reports for defence lawyers, the Crown Prosecution Service and the police. We caught up with Dr Haldane to discuss how CANTAB Insight is integral to his work.  

25 October 2018

CANTAB tests predict functional decline in patients with amnestic mild cognitive impairment

We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.

24 October 2018

Using Bayesian methods to model normative CANTAB cognitive performance across adulthood

At CTAD 2018 we shared our new data on why a Bayesian approach is best to describe normative cognitive performance, especially when making scientifically robust comparisons to neurologically impaired groups. 

web-based testing, wearables, voice-based assessment, voice recognition, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, smartphones, schizophrenia research, schizophrenia, research funding, research, remote testing, regulations, recruitment, prodromal, pro-cognitive, presenteeism, predictive models, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, parkinson's disease, pal, paired associates learning, ots, occupational health, objective measures, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health at work, mental health, mci, major depression, impulsive, ied, hot cognition, high frequency, healthcare, guide, guidance, funding, ert, epidemiology, emotion recognition, ebt, ebbinghaus, early career researchers, early alzheimer's disease, drug development, down syndrome, digital tools, digital health, depression, dementia, cognitive wellbeing, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, cgt, cantab testimonial, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, automatic speech recognition, autism, attention, asd, alzheimer's disease, affective cognition, adolescents, absenteeism,